✦ LIBER ✦

Risk categories and refractory CLL in the era of chemoimmunotherapy

✍ Scribed by Zenz, T.; Gribben, J. G.; Hallek, M.; Dohner, H.; Keating, M. J.; Stilgenbauer, S.

Book ID: 118018308
Publisher: American Society of Hematology
Year: 2012
Tongue: English
Weight: 409 KB
Volume: 119
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2011-11-312421

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fludarabine in the treatment of refracto

Fludarabine in the treatment of refractory lymphocytic leukemia (CLL) and low grade lymphoma (LGL)

✍ Gillis, S.; Dann, E.J.; Rachmilewitz, E.A.; Polliack, A. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 130 KB

The treatment of recurrent/refractory ch

The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulation

✍ Clive S. Zent; Betsy R. LaPlant; Patrick B. Johnston; Timothy G. Call; Thomas M. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

Chemoimmunotherapy with GA101 plus chlor

Chemoimmunotherapy with GA101 plus chlorambucil in patients with chronic lymphocytic leukemia and comorbidity: results of the CLL11 (BO21004) safety run-in

✍ Goede, V; Fischer, K; Busch, R; Jaeger, U; Dilhuydy, M-S; Wickham, N; De Guibert 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 335 KB

Treatment of relapsed and refractory mul

Treatment of relapsed and refractory multiple myeloma in the era of novel agents

✍ Niels W.C.J. van de Donk; Henk M. Lokhorst; Meletios Dimopoulos; Michele Cavo; G 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 474 KB

Biodiversity conservation in the era of

Biodiversity conservation in the era of biofuels: risks and opportunities

✍ Fletcher, Robert J; Robertson, Bruce A; Evans, Jason; Doran, Patrick J; Alavalap 📂 Article 📅 2010 🏛 Ecological Society of America 🌐 English ⚖ 586 KB

Early relapse and refractory disease rem

Early relapse and refractory disease remain risk factors in the anthracycline and autologous transplant era for patients with relapsed/refractory classical Hodgkin lymphoma: a single centre intention-to-treat analysis

✍ Paul Greaves; Andrew Wilson; Janet Matthews; Daniel L. P. Brown; Rebecca Auer; S 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB